Work

Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-γ1 in acute myeloid leukemia cells

Year: 2004

Type: article

Source: Leukemia

DOI: 10.1038/sj.leu.2403461

Authors: R B Walter, B W Raden, J Thompson, D A Flowers, H-P Kiem, I D Bernstein, M L Linenberger

Institutions: Fred Hutch Cancer Center, University of Washington

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Mechanisms of Resistance to Gemtuzumab Ozogamicin, G2819971141, Core Center of Excellence in Hematology, G4797027123

OpenAlex ID: W2025922969

FWCI: 1.175

Cites: 8

Cited by: 18

Related to: 10